Skip to content
R110

Drawing based on the label description. No photo yet.

R110 pill

Pill with imprint R110 is blue, capsule, 20 mm and has been identified as Dabigatran Etexilate Mesylate 110 mg. It is used for blood clots in the veins and blood clots in the lungs. It is supplied by Boehringer Ingelheim Pharmaceuticals Inc.

Dabigatran Etexilate Mesylate 110 mg

Imprint
R110
Strength
110 mg
Used for
Blood clots in the veins and blood clots in the lungs
Color
Blue
Shape
Capsule / oblong
Size
20 mm
Score
No score line
Form
Capsule
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc
NDC
0597-0108, 0597-0108-54, 0597-0108-60

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Dabigatran Etexilate pills and guides

What is Dabigatran Etexilate used for?

Dabigatran Etexilate is used for blood clots in the veins and blood clots in the lungs.

Official uses from the US prescribing label

Reduction of Risk of Stroke and Systemic Embolism in Non-valvular Atrial Fibrillation in Adult Patients

Dabigatran Etexilate Capsules is indicated to reduce the risk of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation.

Treatment of Deep Venous Thrombosis and Pulmonary Embolism in Adult Patients

Dabigatran Etexilate Capsules is indicated for the treatment of deep venous thrombosis and pulmonary embolism in adult patients who have been treated with a parenteral anticoagulant for 5 to 10 days.

Reduction in the Risk of Recurrence of Deep Venous Thrombosis and Pulmonary Embolism in Adult Patients

Dabigatran Etexilate Capsules is indicated to reduce the risk of recurrence of deep venous thrombosis and pulmonary embolism in adult patients who have been previously treated.

Prophylaxis of Deep Vein Thrombosis and Pulmonary Embolism in Adult Patients Following Hip Replacement Surgery

Dabigatran Etexilate Capsules is indicated for the prophylaxis of deep vein thrombosis and pulmonary embolism in adult patients who have undergone hip replacement surgery.

Treatment of Venous Thromboembolic Events in Pediatric Patients

Dabigatran Etexilate Capsules is indicated for the treatment of venous thromboembolic events (VET) in pediatric patients 8 to less than 18 years of age who have been treated with a parenteral anticoagulant for at least 5 days.

Reduction in the Risk of Recurrence of Venous Thromboembolic Events in Pediatric Patients

Dabigatran Etexilate Capsules is indicated to reduce the risk of recurrence of VTE in pediatric patients 8 to less than 18 years of age who have been previously treated.

From the FDA-approved label on DailyMed (published Aug 05, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows R110.
  • It is blue, capsule, 20 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Sold under the brand name Pradaxa.

Ingredients

Active: Dabigatran Etexilate Mesylate

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Dabigatran Etexilate pills